MSB 2.70% 95.0¢ mesoblast limited

Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial, page-13

  1. 3,873 Posts.
    lightbulb Created with Sketch. 1314
    Oh goody, just got back in. Now, wait for it to make the news in the outside world, the first MPC or cellular or "stem cell" treatment to pass a Phase 3 trial with the FDA.
    Last edited by Treed: 20/09/18
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.